Sign In
Buy NVRO
$5.84
+0 (+0%)
At Close: Jul 01, 2025
Levi & Korsinsky, LLP Investigates Nevro Corp. Data Breach
12:30pm, Monday, 14'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 13, 2025 / Nevro Corp.,recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals.This da
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach
12:30pm, Friday, 11'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / Nevro Corp., recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals. This
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Nevro Corp. Customers Whose Data May Have Been Compromised
12:44pm, Thursday, 10'th Apr 2025
NEWTOWN, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations at Nevro Corp. (“Nevro”).
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach
12:30pm, Thursday, 10'th Apr 2025
NEW YORK CITY, NY / ACCESS Newswire / April 10, 2025 / Nevro Corp.,recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals. T
Nevro Corp. Data Breach - Levi & Korsinsky, LLP Launches Investigation
12:30pm, Wednesday, 09'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Nevro Corp., recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals.This da
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach
12:30pm, Tuesday, 08'th Apr 2025
NEW YORK CITY, NY / ACCESS Newswire / April 8, 2025 / Nevro Corp., recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals. T
Nevro Corp. Investigated by Federman & Sherwood for Data Breach
04:24pm, Thursday, 03'rd Apr 2025
OKLAHOMA CITY, April 03, 2025 (GLOBE NEWSWIRE) -- Nevro Corp. investigated by Federman & Sherwood for data breach. On April 3, 2025, Nevro Corp. filed notice of a data breach with the Attorney General
Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report?
12:30pm, Thursday, 03'rd Apr 2025
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock?
Globus Medical completes acquisition of Nevro Corp.
08:31am, Thursday, 03'rd Apr 2025
AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisitio
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of N
Here's Why you Should Retain Nevro Stock in Your Portfolio Now
12:36pm, Wednesday, 19'th Mar 2025
NVRO continues to gain due to its business expansion into the SI joint fusion market and optimistic 2024 results amid a weak SCS market.
Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down
12:40pm, Wednesday, 05'th Mar 2025
NVRO's fourth-quarter earnings surpass the Zacks Consensus Estimate, while worldwide revenues decline year over year. The company continues to incur losses at the operating level.
Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates
06:45pm, Tuesday, 04'th Mar 2025
Nevro (NVRO) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $0.15 per share a year ago.
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
04:15pm, Tuesday, 04'th Mar 2025
REDWOOD CITY, Calif. , March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pa
Shareholder Alert: The Ademi Firm investigates whether Nevro Corp. is obtaining a Fair Price for its Public Shareholders
12:03pm, Monday, 24'th Feb 2025
MILWAUKEE , Feb. 24, 2025 /PRNewswire/ -- The Ademi Firm is investigating Nevro (NYSE: NVRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus Medical
